ZBH vs PODD — Key Metrics
| Metric | ZBH (ZIMMER BIOMET HOLDINGS INC) | PODD (INSULET CORP) |
|---|---|---|
| Price | 103.32 | 139.98 |
| Market Cap | 19.55 Billion | 9.71 Billion |
| P/E (TTM) | 26.03 | 22.8 |
| P/B (Quarterly) | 1.639 | 7.249 |
| P/S (TTM) | 2.28 | 3.04 |
| Net Profit Margin (TTM) | 9.0 | 13.4 |
| Gross Margin (TTM) | 69.7 | 71.9 |
| ROE (TTM) | 6.1 | 29.5 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Underperform
Outperform
Recommendation Summary
Stock ZBH is projected to underperform the market, stock PODD is projected to outperform the market. Upfront Recommendation: PODD.
Financial Metrics
| ZBH | Metrics | PODD |
|---|---|---|
| $103.32 | Price | $139.98 |
| — | Market Capitalization | — |
| 26.03 | Price to Earnings Ratio | 22.8 |
| 2.28 | Price to Sales | 3.04 |
| 15.1 | Price to FCF Ratio | 41.75 |
| 3.27 | Price to Gross Profit | 4.24 |
| 45.18 | Price to R&D | 26.95 |
| 3.81 | Price to Current Assets | 4.76 |
ZBH vs PODD at a glance
Zimmer Biomet Holdings INC (ZBH) and Insulet Corp (PODD) are both Medical Devices companies in the Healthcare sector. ZBH is the larger, at $19.6 billion in market value against $9.7 billion for PODD, about 2.0 times the size.
On trailing-twelve-month figures, ZBH trades at 26.0 times trailing earnings and PODD at 22.8; net profit margins are 9.0% and 13.4%.
The Upfront Investment model currently rates ZBH Underperform and PODD Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.